VY-AADC

Neurocrine Pays $165M to Bankroll Voyager’s Gene Therapy for Parkinson’s
Xconomy
Tue, 01/29/19 - 09:59 am
Voyager Therapeutics
Parkinson's Disease
Neurocrine
VY-AADC
gene therapy